Binding Analysis of 95 HIV gp120 Peptides to HLA-DR1101 and -DR0401 Evidenced Many HLA-Class II Binding Regions on gp120 and Suggested Several Promiscuous Regions
- 1 February 1997
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 14 (2), 91-101
- https://doi.org/10.1097/00042560-199702010-00001
Abstract
To identify HLA-DR-binding peptides within the human immunodeficiency virus (HIV)-1 proteins. 95 overlapping synthetic peptides representing the entire sequence of gp120-LAI were screened for their capacity to bind to two HLA-DR molecules with distant sequences (DR0401 and DR1101). By using a cell surface competitive binding assay, 56 DR-binding peptides were identified, of which 35 bound to both DR1101 and DR0401. A highly significant concordance was evidenced by statistical analysis between binding of peptides to one and to the other DR molecule, suggesting a high proportion of promiscuity among gp120 peptides, even though no clear sequence pattern accounting for such promiscuity was found. DR-binding peptides were located along the entire gp120 sequence. Yet, the majority of them (42 among 56) were concentrated in seven multiagretopic regions that were arbitrarily defined as regions containing four or more overlapping continuous peptides binding to DR1011 and/or DR0401. A good correlation was found between DR-binding regions or DR-binding peptides defined in this study and promiscuous T helper gp120 epitopes previously described in seropositive individuals. All these results suggest that the identification of multiagretopic DR-binding regions may be a great help for the predicition of protein determinants that have the likelihood of being promiscuous T helper epitopes in humans.Keywords
This publication has 21 references indexed in Scilit:
- The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3Nature, 1995
- Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues.The Journal of Experimental Medicine, 1994
- Molecular basis for degenerate T-cell recognition of one peptide in the context of several DR moleculesHuman Immunology, 1994
- Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptideNature, 1994
- Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1Nature, 1993
- Insights on the amino acid side-chain interactions of a synthetic T-cell determinantBiologicals, 1991
- Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell SrfacesInternational Immunology, 1990
- Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cellsEuropean Journal of Immunology, 1989
- Reversal of HLA restriction by a point mutation in an antigenic peptideInternational Immunology, 1989
- Solid Phase Peptide Synthesis. I. The Synthesis of a TetrapeptideJournal of the American Chemical Society, 1963